⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACAD News
Acadia Pharmaceuticals Inc.
BioNJ Elects Board Officers and Trustees
prnewswire.com
GMAB
MRK
AMTX
JNJ
ASND
ACAD
BMY
PFE
PTC
NVS
SNY
CLDX
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
businesswire.com
ACAD
Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union
businesswire.com
ACAD
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
Crystalys Therapeutics Expands Leadership Team with Appointment of Justin Thacker as Chief Financial Officer to Support Advancement of Phase 3 Trials of Dotinurad
prnewswire.com
ABBV
ACAD
ASTX
CADL
The Michael J. Fox Foundation Launches 2026 "Parkinson's IQ + You" Event Series to Educate, Empower and Connect People and Families Living with Parkinson's Disease
prnewswire.com
ACAD
Liberty All-Star® Growth Fund, Inc. December 2025 Monthly Update
businesswire.com
ASG
NVDA
AAPL
MSFT
GOOGL
AMZN
META
OLLI
NTRA
LLY
CW
SMTC
ACAD
IDXX
ROST
CRM
BAH
CYBR
SPOT
SPSC
TTC
TDG
7MM Autism Spectrum Disorder Market Opportunity Assessment and Forecast Report 2024-2034: Entry of the Five Pipeline Products Will Have a Significant Impact on the Market
globenewswire.com
ABR
LLY
PFG
MRK
JNJ
CL
AXSM
ACAD
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
ACAD
Major General Thomas Bouchard, USA (Ret.) Joins Academy Securities’ Advisory Board and Geopolitical Intelligence Group
businesswire.com
ACAD